.

By LACHLAN MOORHEAD

THE medication for an ultra-rare blood disease is still not guaranteed to be subsidised by the Federal Government despite a recent recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC).
Soliris, the most effective treatment available for the rare atypical haemolytic uraemic syndrome (aHUS), was recommended by PBAC to be listed on the Pharmaceutical Benefits Scheme (PBS) at a meeting last month but pricing negotiations between the Federal Government and Soliris’ manufacturer Alexion Pharmaceuticals are still ongoing, with seemingly no end in sight.
Without subsidisation, Soliris is estimated to cost Australian patients roughly $500,000 a year.
Federal MP for La Trobe Jason Wood, who recently met again with nine-year-old aHUS sufferer Holly Van Der Loop and her Narre Warren family, said the process of having Soliris placed on the PBS was only half way.
“It’s great to hear that the PBAC has recommended Soliris to be listed on the PBS, news that we’ve been waiting to hear for a while now,” he said.
“Unfortunately though, we’re only about 50 per cent of the way through the process.
“A positive PBAC recommendation is a very important step in the listing process, but other steps need to be taken before a listing is achieved.
“Pricing negotiations, finalisation of the condition for listing, and quality and availability checks all have to be done before we can breathe a full sigh of relief.”
Holly was diagnosed with aHUS in October 2012, a life-threatening disease that can severely damage the kidneys, heart and brain, and which affects only two in one million Victorians.
Holly’s mother Linda thanked Mr Wood for pushing to have Soliris subsidised, and said the medication was currently beyond the reach of “everyday Australians”.
“I hope that it will be subsidised because if Holly needs it in the future, it’s something that a normal everyday family can’t afford,” she said.
While Holly’s condition has now stabilised, Linda is frighteningly aware of the rate of recurrence of the disease.
“I’m worried that every time she goes to school, she’ll contract an infection which could trigger another aHUS episode,” Linda said.
“I don’t know if Holly’s body could cope with another attack and having plasma exchange again.”
For more information, or to sign the aHUS Patient Support Group Australia petition, visit www.ahus.com.au

Comments are closed.

Your first stop before buying a home. View the whole picture.

More News

Casey councillor Susan Serey is recontesting for a seat in State Parliament. On 15 November, Cr Serey was formally announced as ...

Certified gold The Ramble Tamble Certified Gold Show, the ultimate tribute, dinner and show experience featuring the music of both ...

A spectacular light and lantern festival could be launched by Casey Council at Bunjil Place as early as 2018. Outgoing mayor ...

An 18-year-old accused drug trafficker has said he lied to police when he told them he was couriering cannabis across ...

The first challenge for Upper Beaconsfield archer Shaylen was to make it to national titles. The prodigiously talented nine-year-old more ...

Casey Council is seeking to hold an annual Christian prayer breakfast to pray for and thank emergency services members. Outgoing ...

Latest Sport

Dandenong Stingrays captain Oscar Clavarino possesses genuine leadership, an ability to read the ball as well as anyone in the ...

Despite losing their fourth consecutive match in the opening month of the Victorian Premier Cricket season, Casey-South Melbourne coach Prabath ...

VICTORIAN PREMIER CRICKET PREVIEW – ROUND 4 DANDENONG (1ST) v CASEY-SOUTH MELBOURNE (17TH) Shepley Oval, 28 October from 11am Saturday’s clash for ...